Quick Answer
Evolent Health, Inc. reported Net Income of -$534.51 million for fiscal year 2025.
Evolent Health, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$534.51M | -767.4% |
| 2024 | -$61.62M | +45.5% |
| 2023 | -$113.04M | -489.9% |
| 2022 | -$19.16M | +49.0% |
| 2021 | -$37.60M | +88.8% |
| 2020 | -$334.25M | -10.7% |
| 2019 | -$301.97M | -473.5% |
| 2018 | -$52.66M | +13.2% |
| 2017 | -$60.66M | +62.0% |
| 2016 | -$159.74M | -148.0% |
| 2015 | $332.49M | +1417.0% |
| 2014 | -$25.25M | -226.1% |
| 2013 | $20.02M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$20.86M | +9.8% | -4.9% |
| June 30, 2025 | -$19.90M | -1346.7% | +69.2% |
| March 31, 2025 | -$64.62M | -273.9% | -179.3% |
| September 30, 2024 | -$23.14M | +8.6% | -1549.7% |
| June 30, 2024 | $1.60M | +104.6% | +109.2% |
| March 31, 2024 | -$17.28M | +13.5% | +31.8% |
| September 30, 2023 | -$25.32M | -1292.8% | +26.2% |
| June 30, 2023 | -$34.32M | -648.1% | -71.8% |
- Evolent Health, Inc. showed a decrease of -767.4% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, Evolent Health, Inc.’s net income has declined by 2769.5% (from $20.02 million to -$534.51 million).
- The most recent figure is from Evolent Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: